Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × avelumab × 30 days × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 4 Carcinoma, Transitional Cell 4 Urethral Neoplasms 2 Ureteral Neoplasms 2 Neoplasm Metastasis 2 Carcinoma, Renal Cell 2 Carcinoma, Merkel Cell 2 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Osteosarcoma 1 Metastatic Urothelial Cancer 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Melanoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 10 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Gemcitabine 7 erdafitinib 4 Mitomycin 4 dodecyl maltoside 2 Docetaxel 2 pirarubicin 1 hydroxycamptothecinum 1 Transurethral Resection of Bladder 1 Patient Discharge 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Injections 1 Epirubicin 1 Drainage 1 Cystoscopy 1 BCG Vaccine 1 Accelerometry 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡